Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Adds Another 17 Points. More details...
Development Stage Biotech Is Well-Received. More details...
Winners and Losers. More details...
CBT 200 Drops 11 Points. More details...
CBT 200 Drops A Point During Week. More details...
New Antibody Will Enter Phase II. More details...
CBT 200 Drops 36 Points. More details...
CBT 200 Gains 3 Points. More details...
FDA Approves Two Facilities. More details...
Potential Blockbusters Come With Side Effects. More...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here